Skip to main content

Tweet by Dr. John Cush

View on
Intravenous Immune Globulin in Dermatomyositis

Few drugs have been studied well in the treatment of dermatomyositis (DM) and only recently has intravenous immune globulin (IVIG) been granted FDA approval for the treatment of DM, based on this trial.
https://bit.ly/3Vs2ZCi
Image from Dr. John Cush’s tweet
×